• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Middleby Appoints Glenn Eisenberg To Board of Directors

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    $SOLV
    Medical Specialities
    Health Care
    Medical Specialities
    Health Care
    Get the next $LH alert in real time by email

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members.

    "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation, and board-level oversight will be highly valuable as we advance our operational initiatives and drive sustainable organic growth."

    Mr. Eisenberg brings extensive public company leadership experience spanning life services, industrial manufacturing, and diversified industrial sectors. Most recently he served as Executive Vice President and Chief Financial Officer at Labcorp (NYSE:LH), a $13 billion global life sciences company, where he oversaw financial operations across over 100 countries until his retirement in December 2024. He continues as a Special Advisor to the company. Prior to Labcorp, Mr. Eisenberg served as Executive Vice President of Finance and Administration and Chief Financial Officer from 2002-2014 at The Timken Company, a leading global manufacturer of highly engineered bearings, alloy steels and related products and services. Earlier in his career, he was President and Chief Operating Officer of United Dominion Industries, a diversified industrial manufacturer, now a subsidiary of SPX Corporation where he also held several senior leadership roles in finance, including Executive Vice President and Chief Financial Officer and President of the company's Test Instrumentation segment.

    Mr. Eisenberg currently serves on the Board of Directors of two other public companies. In April 2024 he joined the Board of Directors of Solventum (NYSE:SOLV), and chairs the Audit Committee. In March 2025 he was added to the board of Lumexa Imaging (NASDAQ:LMRI) where he chairs the Audit Committee and is a member of the Compensation Committee. His previous board experience includes serving as lead independent director and chairing governance committees at Alpha Natural Resources Inc., chairing audit committees at U.S. Ecology Inc. and Family Dollar Stores Inc., and serving on the audit committee at Perspecta Inc.

    "Glenn's appointment reflects our strategic focus on enhancing board capabilities with complementary financial and operational expertise," said Gordon O'Brien, Middleby Board Chairman. "His proven ability to lead complex organizations through various business cycles, combined with his deep experience in capital allocation and public company governance, positions him to provide valuable oversight as we execute our pure-play commercial foodservice strategy. We are confident his financial acumen and board leadership will support our commitment to driving sustainable long-term value creation and operational excellence."

    About The Middleby Corporation

    The Middleby Corporation is a global leader in the foodservice industry. The company develops and manufactures a broad line of solutions used in commercial foodservice and food processing. Middleby showcases its advanced solutions in the Middleby Innovation Kitchens for commercial foodservice, and industrial baking and protein Innovation Centers for food processing solutions. For more information about Middleby, please visit www.middleby.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260306461334/en/

    Investors:

    Rebecca Ellin

    SVP of Investor Strategy and Corporate Development

    [email protected]

    Media:

    Darcy Bretz

    VP of Corporate Communications

    [email protected]

    Kate Schneiderman

    Managing Director, ICR

    [email protected]

    Get the next $LH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LH
    $LMRI
    $MIDD
    $SOLV

    CompanyDatePrice TargetRatingAnalyst
    Solventum Corporation
    $SOLV
    3/24/2026$60.00Sell
    Rothschild & Co Redburn
    Lumexa Imaging Holdings Inc.
    $LMRI
    2/9/2026$23.00Outperform → Strong Buy
    Raymond James
    Solventum Corporation
    $SOLV
    1/26/2026$97.00Sector Weight → Overweight
    KeyBanc Capital Markets
    Solventum Corporation
    $SOLV
    1/20/2026$100.00Neutral → Outperform
    Mizuho
    Lumexa Imaging Holdings Inc.
    $LMRI
    1/5/2026$23.00Overweight
    Analyst
    Lumexa Imaging Holdings Inc.
    $LMRI
    1/5/2026$23.00Buy
    Jefferies
    Lumexa Imaging Holdings Inc.
    $LMRI
    1/5/2026$22.00Overweight
    Wells Fargo
    Lumexa Imaging Holdings Inc.
    $LMRI
    1/5/2026Outperform
    William Blair
    More analyst ratings

    $LH
    $LMRI
    $MIDD
    $SOLV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes

    First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams act quickly when every second countsFentanyl Urine Visual Test is available through Labcorp Point of Care, previously known as MEDTOX DiagnosticsBURLINGTON, N.C., April 15, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced the launch of the Labcorp Fentanyl Urine Visual Test, the first U.S. Food and Drug Administration (FDA)-cleared rapid fentanyl test of its kind manufactured in the United States. The test delivers results in just 10 minutes, giving healthcare providers fast, actionable

    4/15/26 7:00:00 AM ET
    $LH
    Medical Specialities
    Health Care

    Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026

    ST. PAUL, Minn., April 14, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) will release its first quarter fiscal 2026 financial results on Tuesday, May 5, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Tuesday, May 5, 2026Time:3:30 p.m. CDT / 4:30 p.m. EDTLocation:https://investors.solventum.com U.S. dial-in+1 (800) 715-9871International dial-in: +1 (646) 307-1963Conference ID:63

    4/14/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Labcorp Introduces AI-Powered Real-World Data Platform with AWS and Datavant to Accelerate Alzheimer's Research

    Platform leverages agentic AI and diverse healthcare datasets to transform and speed drug developmentBURLINGTON, N.C., April 14, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced a new AI-powered real-world data platform, designed to help researchers and biopharmaceutical companies analyze Alzheimer's disease-related data faster. Developed with Amazon Web Services (AWS) and Datavant, the platform provides access to large, diverse datasets and advanced analytics—using deidentified, privacy-protected healthcare data—designed to accelerate scientific discovery, shorten drug development timelines and improve identificatio

    4/14/26 7:00:00 AM ET
    $LH
    Medical Specialities
    Health Care

    $LH
    $LMRI
    $MIDD
    $SOLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Solventum with a new price target

    Rothschild & Co Redburn initiated coverage of Solventum with a rating of Sell and set a new price target of $60.00

    3/24/26 8:51:05 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Lumexa Imaging Holdings upgraded by Raymond James with a new price target

    Raymond James upgraded Lumexa Imaging Holdings from Outperform to Strong Buy and set a new price target of $23.00

    2/9/26 8:16:45 AM ET
    $LMRI
    Medical Specialities
    Health Care

    Solventum upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded Solventum from Sector Weight to Overweight and set a new price target of $97.00

    1/26/26 8:32:07 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $LH
    $LMRI
    $MIDD
    $SOLV
    SEC Filings

    View All

    SEC Form DEFA14A filed by Labcorp Holdings Inc.

    DEFA14A - LABCORP HOLDINGS INC. (0000920148) (Filer)

    4/10/26 12:10:03 PM ET
    $LH
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Labcorp Holdings Inc.

    DEF 14A - LABCORP HOLDINGS INC. (0000920148) (Filer)

    4/10/26 12:01:08 PM ET
    $LH
    Medical Specialities
    Health Care

    Lumexa Imaging Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Lumexa Imaging Holdings, Inc. (0002071288) (Filer)

    4/9/26 5:11:27 PM ET
    $LMRI
    Medical Specialities
    Health Care

    $LH
    $LMRI
    $MIDD
    $SOLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wilcox Mary T

    4 - Solventum Corp (0001964738) (Issuer)

    3/30/26 7:45:23 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Cox Carrie Smith

    4 - Solventum Corp (0001964738) (Issuer)

    3/30/26 7:44:33 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Devore Susan D.

    4 - Solventum Corp (0001964738) (Issuer)

    3/30/26 7:43:43 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $LH
    $LMRI
    $MIDD
    $SOLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wendell Amy Mcbride bought $100,344 worth of shares (1,475 units at $68.03), increasing direct ownership by 41% to 5,039 units (SEC Form 4)

    4 - Solventum Corp (0001964738) (Issuer)

    3/11/26 6:31:11 AM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Director Garden Edward P bought $14,996,481 worth of shares (102,903 units at $145.73) (SEC Form 4)

    4 - MIDDLEBY Corp (0000769520) (Issuer)

    12/15/25 5:42:41 PM ET
    $MIDD
    Industrial Machinery/Components
    Industrials

    Director Nerbonne Robert A bought $100,248 worth of shares (780 units at $128.52) (SEC Form 4)

    4 - MIDDLEBY Corp (0000769520) (Issuer)

    12/9/25 9:20:27 PM ET
    $MIDD
    Industrial Machinery/Components
    Industrials

    $LH
    $LMRI
    $MIDD
    $SOLV
    Leadership Updates

    Live Leadership Updates

    View All

    Middleby Appoints Brittany Cerwin as Chief Financial Officer

    Bryan Mittelman to Serve as Special Advisor Through Completion of Food Processing Spin-Off The Middleby Corporation ("Middleby") (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Brittany Cerwin as Chief Financial Officer, effective immediately. Ms. Cerwin succeeds Bryan Mittelman, who has served as CFO since 2019 and will transition to the role of Special Advisor to the Chief Executive Officer. "Brittany has been an integral part of the Middleby corporate finance team since joining us fifteen years ago. Her financial expertise and exceptional leadership are highly respected across the organization," said Tim FitzGerald, Middleby Chief Execut

    3/25/26 7:00:00 AM ET
    $MIDD
    Industrial Machinery/Components
    Industrials

    Middleby Appoints Glenn Eisenberg To Board of Directors

    The Middleby Corporation (NASDAQ:MIDD), a global leader in the foodservice industry, today announced the appointment of Glenn Eisenberg to its Board of Directors, effective March 1. With the addition of Mr. Eisenberg, the Middleby Board expands to twelve members. "We are pleased to welcome Glenn Eisenberg to the Middleby Board. His deep experience will be an immediate asset as we execute our strategic transformation," said Tim FitzGerald, Middleby CEO. "Glenn has a proven 20-year track record of success as a public company CFO and senior operating executive across complex global manufacturing businesses. His expertise in financial discipline, industrial manufacturing, capital allocation,

    3/6/26 7:00:00 AM ET
    $LH
    $LMRI
    $MIDD
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Labcorp Appoints John H. Sampson, M.D., Ph.D., to Board of Directors

    BURLINGTON, N.C., Feb. 9, 2026 /PRNewswire/ -- Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced the appointment of John H. Sampson, M.D., Ph.D., MHSc, MBA, to its Board of Directors, effective February 9, 2026. Dr. Sampson serves as vice chancellor for health affairs and dean of the University of Colorado Anschutz School of Medicine at the CU Anschutz medical campus. As a nationally recognized neurosurgeon, physician-scientist and academic leader, Dr. Sampson brings extensive experience spanning clinical care, biomedical r

    2/9/26 8:30:00 AM ET
    $LH
    Medical Specialities
    Health Care

    $LH
    $LMRI
    $MIDD
    $SOLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Middleby Corporation

    SC 13G/A - MIDDLEBY Corp (0000769520) (Subject)

    11/14/24 4:26:26 PM ET
    $MIDD
    Industrial Machinery/Components
    Industrials

    Amendment: SEC Form SC 13G/A filed by Solventum Corporation

    SC 13G/A - Solventum Corp (0001964738) (Subject)

    11/12/24 5:47:11 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Solventum Corporation

    SC 13G/A - Solventum Corp (0001964738) (Subject)

    11/4/24 1:47:43 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    $LH
    $LMRI
    $MIDD
    $SOLV
    Financials

    Live finance-specific insights

    View All

    Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026

    ST. PAUL, Minn., April 14, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) will release its first quarter fiscal 2026 financial results on Tuesday, May 5, 2026, after the U.S. financial markets close. Following the release, Solventum management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast. Earnings webcast details: Date: Tuesday, May 5, 2026Time:3:30 p.m. CDT / 4:30 p.m. EDTLocation:https://investors.solventum.com U.S. dial-in+1 (800) 715-9871International dial-in: +1 (646) 307-1963Conference ID:63

    4/14/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care

    Labcorp Declares Quarterly Dividend

    BURLINGTON, N.C., April 9, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 11, 2026, to stockholders of record as of the close of business on May 29, 2026. About LabcorpLabcorp (NYSE:LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident

    4/9/26 6:50:00 AM ET
    $LH
    Medical Specialities
    Health Care

    Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance

    Reported sales decreased 3.7%; organic sales increased 3.5%Introduces full-year 2026 organic sales growth, adjusted EPS and free cash flow guidanceST. PAUL, Minn., Feb. 26, 2026 /PRNewswire/ -- Solventum (NYSE:SOLV) today reported financial results for the fourth quarter and year ended December 31, 2025. Fourth Quarter 2025 HighlightsSales of $2 billion decreased 3.7% on a reported basis; an increase of 3.5% on an organic basisGAAP diluted earnings per share of $0.36; adjusted diluted earnings per share of $1.57Operating cash flow of $96 million; free cash flow of $33 million"So

    2/26/26 4:05:00 PM ET
    $SOLV
    Medical/Dental Instruments
    Health Care